We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $112M invested in State Street SPDR S&P Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
2% less funds holding
Funds holding: 81 → 79 (-2)
5.98% less ownership
Funds ownership: 47.65% → 41.66% (-6%)
12% less capital invested
Capital invested by funds: $127M → $112M (-$14.9M)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
28% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 25
Holders
79
Holders Change
-2
Holders Change %
-2.47%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
25
Closed
13
Calls
$344K
Puts
–
Net Calls
+$344K
Net Calls Change
+$119K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$5.05M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$5.04M |
| 3 |
CI
CX Institutional
Auburn,
Indiana
|
+$2.15M |
| 4 |
FCM
Fortis Capital Management
Bellevue,
Washington
|
+$2.01M |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
+$1.2M |
Top Sellers
| 1 |
FMI
Factory Mutual Insurance
Waltham,
Massachusetts
|
-$10.6M |
| 2 |
Goldman Sachs
New York
|
-$10.4M |
| 3 |
Morgan Stanley
New York
|
-$3.35M |
| 4 |
JP Morgan Chase
New York
|
-$2.58M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.76M |
